We have recently shown that
5-Fluorouracil (5-FU) suppresses the
transcription factor NF-kappaB in human
salivary gland cancer cells (cl-1) by mediating upregulation of
IkappaB-alpha expression. However, the precise mechanism involved in this action has not yet been elucidated. IkappaB
kinases (
IKK-alpha and
IKK-beta) are the key components of the IKK complex that mediates activation of
NF-kappaB in response to external stimuli such as
cytokines. In addition,
NF-kappaB-inducing kinase (NIK) and
mitogen-activated protein kinase kinase kinase 1 (MEKK-1), both of which are the upstream
kinases for the IKKs, interact with and activate the IKKs. Thus, we investigated the molecular mechanisms involved in the suppression of
NF-kappaB by
5-FU. Although
5-FU did not affect the expression levels of IKKs, NIK, or MEKK-1, IKK activity in cl-1 cells was suppressed at both 6 h and 12 h
after treatment with 2 microgram/ml
5-FU. Moreover, when cells were treated with various concentrations of
5-FU for 12 h, the concentration of 2 microgram/ml efficiently inhibited the IKK activity as compared to 1, 5, or 10 microgram/ml. The expression of Fas-associated death domain-like
interleukin 1-converting
enzyme-inhibitory
protein (FLIP), which acts as an inhibitor of an initiator
caspase (caspase-8), was down-regulated by
5-FU treatment in cl-1 cells. Apoptosis, as evidenced by cleavage of
poly(ADP-ribose) polymerase through the action of an executioner
caspase (caspase-3), was also clearly observed. Thus, these results suggest that
5-FU induction of apoptosis in cl-1 cells may be mediated by suppression of
NF-kappaB via inhibition of IKK activity.